SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-038514
Filing Date
2023-08-04
Accepted
2023-08-04 15:09:55
Documents
82
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-20230630.htm   iXBRL 10-Q 3054484
2 EX-31.1 eypt-ex31_1.htm EX-31.1 16657
3 EX-31.2 eypt-ex31_2.htm EX-31.2 17218
4 EX-32.1 eypt-ex32_1.htm EX-32.1 7193
5 EX-32.2 eypt-ex32_2.htm EX-32.2 7373
  Complete submission text file 0000950170-23-038514.txt   10387873

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eypt-20230630_pre.xml EX-101.PRE 378314
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eypt-20230630_lab.xml EX-101.LAB 490433
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eypt-20230630_def.xml EX-101.DEF 237241
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eypt-20230630.xsd EX-101.SCH 63479
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eypt-20230630_cal.xml EX-101.CAL 53276
76 EXTRACTED XBRL INSTANCE DOCUMENT eypt-20230630_htm.xml XML 1994102
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 231143649
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services